|
T. B. Cumming, J. Bernhardt, T. Linden
The Montreal cognitive assessment short cognitive evaluation in a large stroke trial
|
4-7 |
|
M.M.A. Conijn, R.P. Kloppenborg, A. Algra, W.P.Th.M. Mali, L.J. Kappelle, K.L. Vincken, M.I. Geerlings for the SMART Study Group
Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease. The Second Manifestations of ARTerial disease- Magnetic Resonance (SMART-MR) Study
|
8-14 |
|
D. Staykov, I. Wagner, B. Volbers, E.-M. Hauer, A. Doerfler, S. Schwab, J. Bardutzky
Natural course of perihemorrhagic edema after intracerebral hemorrhage
|
15-20 |
|
M. Rodríguez-Yáñez, T. Sobrino, S. Arias, F. Vázquez-Herrero, D. Brea, M. Blanco, R. Leira, M. Castellanos, J. Serena, J. Vivancos, A. Dávalos, J. Castillo
Early biomarkers of clinical–diffusion mismatch in acute ischemic stroke
|
21-27 |
|
A. Biffi, L. Cortellini, C.M. Nearnberg, A.M. Ayres, K. Schwab, A.J. Gilson, N.S. Rost, J.N. Goldstein, A. Viswanathan, S.M. Greenberg, J. Rosand
Body mass index and etiology of intracerebral hemorrhage
|
28-34 |
|
B.M. Kim, Y.S. Shin, S.-H. Kim, S.H. Suh, Y.-K. Ihn, D.I. Kim, D.J. Kim, S.I. Park
Incidence and risk factors of recurrence after endovascular treatment of intracranial vertebrobasilar dissecting aneurysms
|
35-42 |
|
J.S. Lees, N.K. Mishra, M. Saini, P.D. Lyden, A. Shuaib; от имени the Virtual International Stroke Trials Archive (VISTA) Collaborators
Low body temperature does not compromise the treatment effect of alteplase
|
43-46 |
|
M. Siebler, M.G. Hennerici, D. Schneider, G.M. von Reutern, R.J. Seitz, J. Röther, O.W. Witte, G. Hamann, U. Junghans, A. Villringer, J.B. Fiebach
Safety of tirofiban in acute ischemic stroke. The SaTIS trial
|
47-53 |
|
V. Valsecchi, G. Pignataro, A. Del Prete, R. Sirabella, C. Matrone, F. Boscia, A. Scorziello, M.J. Sisalli, E. Esposito, N. Zambrano, G. Di Renzo, L. Annunziato
NCX1 is a novel target gene for hypoxia-inducible factor-1 in ischemic brain preconditioning
|
54-65 |
|
S. Rohde, S. Haehnel, C. Herweh, M. Pham, S. Stampfl, P.A. Ringleb, M. Bendszus
Mechanical thrombectomy in acute embolic stroke preliminary results with the revive device
|
66-68 |
|
T. Steiner
Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: yes
|
69-70 |
|
S. Schulman
Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: no
|
71-72 |
|
C.A. Molina, M.H. Selim
The dilemma of resuming anticoagulation after intracranial hemorrhage. Little evidence facing big fears
|
73-74 |
|
V.L. Feigin, R. Krishnamurthi
Stroke prevention in the developing world
|
75-79 |
|
T. Gaberel, C. Magheru, J.-J. Parienti, H.B. Huttner, D. Vivien, E. Emery
Intraventricular fibrinolysis versus external ventricular drainage alone in intraventricular hemorrhage. A meta-analysis
|
80-88 |
|
A. Banerjee, F. Marín, G.Y.H. Lip
A new landscape for stroke prevention in atrial fibrillation. Focus on new anticoagulants, antiarrhythmic drugs, and devices
|
89-96 |
Русский
